Celularity Inc. (CELU) vs Spectral AI, Inc. (MDAI)
A side-by-side comparison of Celularity Inc. and Spectral AI, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CELU
Celularity Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 3:02 PM EDT
MDAI
Spectral AI, Inc.
$1.69HealthcareDelayed quote: Oct 6, 2026, 3:04 PM EDT
Total return — CELU vs MDAI
growth of $100 · dividends reinvested · last 5yCELU -98.3% (-55.8%/yr)MDAI -82.6% (-29.5%/yr)MDAI compounded faster over this window
Log scale — wide-divergence pair
CELU MDAI
CELU vs MDAI: by the numbers
- •MDAI is the larger company ($54M vs $46M market cap).
- •Both run net losses; MDAI's is the smaller (-69.27% vs -375.77% net margin).
Metrics side by side
Valuation
| Metric | CELU | MDAI |
|---|---|---|
| P/S ratio | 2.44 | 3.54 |
Profitability
| Metric | CELU | MDAI |
|---|---|---|
| Gross margin | 79.62% | 41.51% |
| Operating margin | -230.92% | -43.78% |
| Net margin | -375.77% | -69.27% |
| ROIC | -192.99% | -353.68% |
Growth (annualized)
| Metric | CELU | MDAI |
|---|---|---|
| Revenue CAGR (5Y) | 8.31% | N/A |
| Total return CAGR (5Y) | -52.57% | -29.57% |
Frequently asked
- How have CELU and MDAI total returns compared?
- Over the past 5 years, CELU delivered -52.57% and MDAI delivered -29.57% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.